Why the study?
Does long-term medical blood pressure normalization improve coronary flow reserve in patients with arterial hypertension, angina pectoris, and normal epicardial coronary arteries?
Does long-term medical blood pressure normalization improve coronary flow reserve in patients with arterial hypertension, angina pectoris, and normal epicardial coronary arteries?
Long-term medical blood pressure normalization improves coronary flow reserve in hypertensive patients with angina and normal epicardial coronary arteries, likely through regression of microvascular alterations.
Answers are grounded in this paper and cite their sources.
BP normalization may enhance microvascular function in hypertensive angina; hypothesis-generating and should not change practice without RCTs.
Patients with arterial hypertension often have angina pectoris and a positive exercise tolerance test, even when their epicardial coronary arteries are of normal anatomic appearance. In these patients, coronary vasodilator capacity is frequently impaired by 30-50%, predominantly owing to microvascular alterations. These include medical thickening, decreased capillary density, perivascular fibrosis, and an impaired endothelium-dependent coronary vasodilation. An antihypertensive treatment that can be considered cardioreparative restores myocardial structure through both regression of myocardial fibrosis and regression of the structural coronary microvascular alterations. We believe that this is the first clinical study to show that coronary flow reserve was considerably improved after long-term medical blood pressure normalization.
No takes yet. Share an insight, caveat, or question.
Motz et al. (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: